Atlas Trials

Human Metapneumovirus and Human Parainfluenza Infection

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Human Metapneumovirus and Human Parainfluenza Infection

RecordFirmDate
Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure (NCT04144348)ModernaTX, Inc.2019-11-04
Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults (NCT03392389)ModernaTX, Inc.2017-12-04

Track Human Metapneumovirus and Human Parainfluenza Infection automatically

Every clearance here is in the API, with alerts when new ones post.